These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37187260)

  • 1. Using Counter Equilibrium Dialysis (CED) to Increase Confidence in the Measurement of Free Fraction for Challenging Compounds.
    Huang J; Yan Z; Cai J
    J Pharm Sci; 2023 Sep; 112(9):2561-2569. PubMed ID: 37187260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy for Determining the Free Fraction of Labile Covalent Modulators in Plasma Using Equilibrium Dialysis.
    Leung C; Kenny JR; Hop CECA; Yan Z
    J Pharm Sci; 2020 Oct; 109(10):3181-3189. PubMed ID: 32663597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Confidence in the Determination of Free Fraction for Highly Bound Drugs Using Bidirectional Equilibrium Dialysis.
    Chen YC; Kenny JR; Wright M; Hop CECA; Yan Z
    J Pharm Sci; 2019 Mar; 108(3):1296-1302. PubMed ID: 30326208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Protein Binding of Challenging Compounds.
    Riccardi K; Cawley S; Yates PD; Chang C; Funk C; Niosi M; Lin J; Di L
    J Pharm Sci; 2015 Aug; 104(8):2627-36. PubMed ID: 26037784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical and Experimental Validation of Flux Dialysis Method: An Improved Approach to Measure Unbound Fraction for Compounds with High Protein Binding and Other Challenging Properties.
    Kalvass JC; Phipps C; Jenkins GJ; Stuart P; Zhang X; Heinle L; Nijsen MJMA; Fischer V
    Drug Metab Dispos; 2018 Apr; 46(4):458-469. PubMed ID: 29437872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying Two Orthogonal Methods to Assess Accuracy of Plasma Protein Binding Measurements for Highly Bound Compounds.
    Ryu S; Riccardi K; Patel R; Zueva L; Burchett W; Di L
    J Pharm Sci; 2019 Nov; 108(11):3745-3749. PubMed ID: 31419399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Competitive Equilibrium Dialysis Approach for Assessing the Impact of Protein Binding on Clearance Predictions.
    Jones RS; Chang JH; Flores M; Brecht E
    J Pharm Sci; 2021 Jan; 110(1):536-542. PubMed ID: 32941852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the Time to Reach Equilibrium for Improved Estimation of the Unbound Fraction of Compounds in Equilibrium Dialysis Using kinetic Modeling.
    Bae C; Chung G; Chung SJ
    J Pharm Sci; 2023 Nov; 112(11):2901-2909. PubMed ID: 37392902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing the Accuracy of Plasma Protein Binding Measurement for Highly Bound Compounds Using the Dilution Method.
    Ryu S; Tess D; Di L
    AAPS J; 2022 Dec; 25(1):7. PubMed ID: 36471200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid equilibrium dialysis, ultrafiltration or ultracentrifugation? Evaluation of methods to quantify the unbound fraction of substances in plasma.
    Dimitrijevic D; Fabian E; Funk-Weyer D; Landsiedel R
    Biochem Biophys Res Commun; 2023 Apr; 651():114-120. PubMed ID: 36812744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enabling direct and definitive free fraction determination for highly-bound compounds in protein binding assay.
    Zhang J; Pikul G; Horch J; Konovalov D; Li S; Cvijic ME; Shou W; Weller H
    J Pharm Biomed Anal; 2021 Feb; 194():113765. PubMed ID: 33272788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methods.
    Metsu D; Lanot T; Fraissinet F; Picot M; Concordet D; Cabrol M; Dubois-Galopin F; Chatelut E; Delobel P; Gandia P
    Clin Chim Acta; 2018 Apr; 479():56-65. PubMed ID: 29277535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugs.
    Zamek-Gliszczynski MJ; Ruterbories KJ; Ajamie RT; Wickremsinhe ER; Pothuri L; Rao MV; Basavanakatti VN; Pinjari J; Ramanathan VK; Chaudhary AK
    J Pharm Sci; 2011 Jun; 100(6):2498-507. PubMed ID: 21213309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the accuracy of unbound fraction measurement of drug-protein binding by preconditioning the RED membrane inserts.
    Ye Z; Chen Q
    Bioanalysis; 2020 Dec; 12(23):1699-1708. PubMed ID: 33179537
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of pH on plasma protein binding in equilibrium dialysis.
    Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
    Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Method for Preventing Non-specific Binding in Equilibrium Dialysis Assays Using Solutol® as an Additive.
    Srivastava A; Pike A; Williamson B; Fenner K
    J Pharm Sci; 2021 Mar; 110(3):1412-1417. PubMed ID: 33248055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a higher-throughput equilibrium dialysis assay for plasma protein binding.
    van Liempd S; Morrison D; Sysmans L; Nelis P; Mortishire-Smith R
    J Lab Autom; 2011 Feb; 16(1):56-67. PubMed ID: 21609686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small volume rapid equilibrium dialysis (RED) measures effects of interstitial parameters on the protein-bound fraction of topical drugs.
    Wiltschko L; Roblegg E; Raml R; Birngruber T
    J Pharm Biomed Anal; 2023 Sep; 234():115571. PubMed ID: 37527618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.